Anti-inflammatory Effects of a P-coumaric Acid and Kojic Acid Derivative in LPS-stimulated RAW264.7 Macrophage Cells

Numerous derivatives of natural substances have been synthesized to improve their functionality while avoiding the risk of side effects. Both kojic acid and p-coumaric acid are natural products with known anti-inflammatory properties. In this study, we synthesized an ester derivative of kojic acid a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology and bioprocess engineering 2019, 24(4), , pp.653-657
Hauptverfasser: Lee, Miri, Rho, Ho Sik, Choi, Kyungoh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Numerous derivatives of natural substances have been synthesized to improve their functionality while avoiding the risk of side effects. Both kojic acid and p-coumaric acid are natural products with known anti-inflammatory properties. In this study, we synthesized an ester derivative of kojic acid and p-coumaric acid, 5-Hydroxy-4-oxo-4H-pyran-2-yl-methyl (E)-3-(3-hydroxyphenyl) acrylate (compound 3 ), and evaluated its synergistic anti-inflammatory effects. To determine the anti-inflammatory activity of compound 3 in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells, the degree of inhibition of nitric oxide (NO) production, a typical inflammatory mediator, was measured. Kojic acid and p-coumaric acid individually showed no inhibition at 100 μM, whereas compound 3 showed 60% inhibition at the same concentration. Furthermore, we investigated the change in activity of NF-κ B, a key transcription factor in inflammatory response, using RAW264.7 Gaussia luciferase reporter cells. Compound 3 suppressed the activation of NF-κB by approximately 32% at 25 μM. However, 200 μM of kojic acid and p-coumaric acid inhibited NF-κB activation by 20% and 15%, respectively. Taken together, our data suggest that the anti-inflammatory effect of compound 3 is due, at least in part, to the inhibition of NF-κB activation.
ISSN:1226-8372
1976-3816
DOI:10.1007/s12257-018-0492-1